This finding implicates D2 blockade (or, in the case of aripiprazole, modulation of DA activity) as the primary therapeutic mechanism. There may also be an excess activity of serotonin or hyper excitability of 5HT2A/C receptors as evident by use of atypical antipsychotics like clozapine and others mainly for negative symptoms.